Zhu Zhiguo, Jiuxin Traditional Chinese Medicine: From Extensive To High Quality Development Of Science And Technology Enabling New Era Of Traditional Chinese Medicine Industry System

The combination of traditional Chinese and Western medicine in the prevention and treatment of new crown pneumonia showed good curative effect, making the development of traditional Chinese medicine in the market after the epidemic.

On September 26, Zhu Zhiguo, general manager of Jiuzhou tongjiuxin traditional Chinese medicine group, said at the "2020 (fourth) China big health industry summit" sponsored by the 21st century economic report: "for Chinese medicine, the core core is quality, but this is exactly the factor restricting the development of the current Chinese Medicine industry. The inheritance of traditional Chinese medicine should first consolidate its foundation, and the quality is fundamental. The industry should establish a key quality control standard system of the whole chain from Chinese herbal medicine, decoction pieces, Chinese patent medicine and classic famous prescriptions, improve the production standard and quality of traditional Chinese medicine, and establish the whole process traceability system of traditional Chinese medicine products

In 2019, the scale of China's traditional Chinese medicine industry will reach 652 billion yuan, with an increase rate of 3.6% from 7.8% the previous year. Before 2015, the development speed of Chinese medicine industry was relatively fast, but since then, the growth rate has declined.

In Zhu Zhiguo's view, the core factor of the decline in the growth rate of traditional Chinese medicine industry is that the society has different views on traditional Chinese medicine, and traditional Chinese medicine lacks evidence-based medicine and standardization. But the industry after the labor pains will bring new life, and change the situation that inferior goods drive out good ones in the past, and good products will become popular.

The data shows that in the 46 batches of unqualified information released by the State Drug Administration in 2017, the unqualified rate of Chinese Herbal Pieces accounted for 65.98%, among which there are many well-known Chinese medicine and Chinese patent medicine enterprises.

Zhu Zhiguo. Information map

"The quality of traditional Chinese medicine is uneven, including nonstandard planting process of production source, blind introduction, adulteration and other quality problems, which limit the industrialization development of traditional Chinese medicine. The quality control and evaluation system of traditional Chinese medicine products need to be improved due to the lack of combination of quality and efficacy evaluation and the imperfect evaluation system Zhu pointed out that the current situation of traditional Chinese medicine is backward in science and technology, lack of independent technology and equipment, lack of high-quality technology and equipment, and lack of high-quality and low-level intellectual property rights.

With the gradual aging of Chinese society and the continuous expansion of chronic disease population in China, the demand for traditional Chinese medicine service, prevention and treatment of disease, and health preservation with the same source of medicine and food are increasing. Under the epidemic situation, the combination of traditional Chinese medicine and Western medicine has achieved good prevention and control effect, which has improved the acceptance of traditional Chinese medicine from all walks of life. Under the opportunity and the development of traditional Chinese medicine industry in the new era. In 2017, the state promulgated the TCM law and a series of macro planning and industrial policies.

Zhu Zhiguo analyzed and said: "in the new era of traditional Chinese medicine, enterprises should strengthen the extension of industrial chain, shift from single production type to combination of production and service, combination of production and circulation, decocting and intelligent distribution, etc., and brand large varieties; from the perspective of products, it is necessary to innovate the value and use of traditional Chinese medicine products, and change to the direction of health products; from the perspective of channels, it is necessary to break through the traditional marketing channels and carry out comprehensive measures Channel development, under the influence of Internet technology, pay attention to the integration and change of multi-channel; through the combination of traditional Chinese medicine and industrial intelligent manufacturing, improve the automation efficiency and control ability, and strengthen the intelligence and automation of production

At present, Jiuxin traditional Chinese medicine has established the whole industry chain of traditional Chinese medicine industry, and the company's revenue has reached 3.3 billion yuan in 2019. In terms of quality control and innovation, Jiuxin has set up a general research institute and 15 regional branches; in terms of planting, purchasing and marketing, it has set up 8 gap bases for Chinese herbal medicines and 22 companies for producing traditional Chinese medicine materials; in terms of quality control of drug procurement and production, it has set up 9 GMP production enterprises with a layout of more than 160 TCM quality inspection teams; in terms of terminal marketing, it has set up 70 GSP marketing agencies and more than 1100 people In terms of TCM diagnosis and treatment services, it has set up 5 modern TCM museums and 10 smart TCM rooms; in terms of information technology, it has set up an e-commerce platform for traditional Chinese medicine and a technical team of more than 40 people.

Zhu Zhiguo concluded: "the construction of the new Chinese medicine industry system should take agriculture as the basis of traditional Chinese medicine, ensure the quality of drugs, make the traditional Chinese medicine business as the link, take the traditional Chinese medicine industry as the main body, upgrade the industry from extensive type to high-quality development type, and run through the whole industry chain through scientific and technological innovation."

?